| Literature DB >> 12414226 |
Franklin G Miller1, Donald L Rosenstein.
Abstract
Clinical investigators rarely describe the rationale for ethically controversial features of study design or procedures instituted to enhance the protection of patients taking part in research, or how they ensured informed consent. We recommend a policy of extensive reporting of pertinent ethical issues to promote public accountability for clinical research. Guidelines are presented, and possible objections to this recommended policy are addressed.Entities:
Keywords: Biomedical and Behavioral Research
Mesh:
Year: 2002 PMID: 12414226 DOI: 10.1016/S0140-6736(02)11346-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321